Novel Therapies for an Aging Population-Reference-Cited by-同舟云学术

Novel Therapies for an Aging Population

Published:2019-04-23 Issue:16 Volume:321 Page:1567
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Gurwitz Jerry H.¹²³,Pearson Steven D.³

Affiliation:

1. Meyers Primary Care Institute, a joint endeavor of University of Massachusetts Medical School, Fallon Health, and Reliant Medical Group, Worcester

2. Division of Geriatric Medicine, University of Massachusetts Medical School, Worcester

3. Institute for Clinical & Economic Review, Boston, Massachusetts

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

http:///jama/article-pdf/321/16/1567/17503482/jama_gurwitz_2019_vp_190036.pdf

Reference7 articles.

1. Why the ethics of parsimonious medicine is not the ethics of rationing.;Tilburt;JAMA,2013

2. Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy.;Maurer;N Engl J Med,2018

3. Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction.;González-López;Eur Heart J,2015

4. Inclusion across the lifespan: NIH policy for clinical research.;Bernard;JAMA,2018

5. CubanskiJ, NeumanT. The facts on Medicare spending and financing. Henry J. Kaiser Family Foundation. https://www.kff.org/medicare/issue-brief/the-facts-on-medicare-spending-and-financing. Published June 22, 2018. Accessed January 15, 2019.

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Flourishing electronic textiles towards pervasive, personalized and intelligent healthcare;Soft Science;2024-01-04

2. Smartphone- and Paper-Based Delivery of Balance Intervention for Older Adults Are Equally Effective, Enjoyable, and of High Fidelity: A Randomized Controlled Trial;Sensors;2023-08-27

3. Self-Compassion and Positive Aging;Mindfulness in Behavioral Health;2023

4. Triboelectricity: New paradigms for energy harvesting and point-of-care applications;Materials Today: Proceedings;2023

5. Towards sustainability and affordability of expensive cell and gene therapies? Applying a cost-based pricing model to estimate prices for Libmeldy and Zolgensma;Cytotherapy;2022-12